Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Lundbeck Limited
Lundbeck House, Caldecotte Lake Business Park, Caldecotte, Milton Keynes, MK7 8LG
Telephone: +44 (0)1908 649 966
Fax: +44 (0)1908 647 888
WWW: http://www.lundbeck.co.uk
Medical Information Direct Line: +44 (0)1908 638 972
Medical Information e-mail: ukmedicalinformation@lundbeck.com
Customer Care direct line: +44 (0)1908 638 935

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 02/11/2011
PIL Ebixa 10 mg Film-Coated Tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 02/11/2011 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to manufacturer contact details
Updated on 04/04/2011 and displayed until 02/11/2011
Reasons for adding or updating:
  • Change of inactive ingredient
  • Change to appearance of the medicine
  • Change to warnings or special precautions for use
Updated on 19/07/2010 and displayed until 04/04/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
Updated on 22/01/2009 and displayed until 19/07/2010
Reasons for adding or updating:
  • PIL Retired pending re-submission
  • Change to date of revision
  • Change to side-effects
Updated on 23/09/2008 and displayed until 22/01/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change to dosage and administration
Updated on 25/06/2008 and displayed until 23/09/2008
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 02/01/2008 and displayed until 25/06/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to date of revision
Updated on 01/06/2006 and displayed until 02/01/2008
Reasons for adding or updating:
  • Change to drug interactions
  • Change to side-effects
Updated on 02/02/2006 and displayed until 01/06/2006
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change to side-effects
  • Change to Further Information section
  • Change to date of revision
Updated on 09/09/2002 and displayed until 02/02/2006
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
  memantine hydrochloride